Dr. Alma S. Rigonan, MD

Dr. Rigonan practices at Corpus Christi Allergy Asthma Dermatology in Corpus Christi, Texas.

Dr. Rigonan's NPI, 1083690390, was assigned on December 19, 2005. Dr. Rigonan graduated from De La Salle University College of Medicine in 1991. Dr. Rigonan holds Texas license K4211.

Dr. Rigonan's primary practice is Corpus Christi Allergy Asthma Dermatology, at 3314 S Alameda St, Corpus Christi, TX 78411 in Nueces County. The practice phone is (361) 888-6782.

Dr. Rigonan's primary practice is Corpus Christi Allergy Asthma Dermatology in Corpus Christi, Texas. The medical group on file is Children's Physician Services of South Texas. Dmand AI also links Dr. Rigonan to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rigonan practices. Vendor and product names are available with a free account.

Pediatrics is Dr. Rigonan's primary specialty in the NPI Registry, under taxonomy code 208000000X. Dr. Rigonan is board certified in pediatrics by the American Board of Pediatrics. Dr. Rigonan is licensed in Texas.

Dmand AI lists acute skin infection, asthma, benign or precancerous skin growths, chronic hypertension, chronic nasal allergies, chronic sinusitis, conjunctivitis and ear eustachian tube disorders among the conditions Dr. Rigonan treats.

CMS data shows 9,558 Medicare services from Dr. Rigonan across 10 procedure codes in 2024, for 219 Medicare patients. Medicare paid $114,960 for them. Every service was in an office.

CMS counts 219 Medicare patients who saw Dr. Rigonan in 2024. The largest group is 65 to 74, with 101 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rigonan's median patient age at 54, with 60% women.

In 2024, Dr. Rigonan wrote 981 Medicare Part D claims for 268 patients. 89% of them were for generic drugs. CMS names the drug for 795 of them, across 24 drugs with 11 or more claims each, at $31,082 in total drug cost. In 2023, CMS named 478 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Rigonan for performance year 2024, reported as part of a group. Dr. Rigonan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 38 procedures of removal or shaving of skin growth by Dr. Rigonan, more than 77% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Rigonan.

CMS Open Payments shows 77 general payments to Dr. Rigonan from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $675.

Dr. Rigonan graduated from De La Salle University College of Medicine in 1991. Dr. Rigonan is a member of AAP, ACAAI, Corpus Christi Pediatric Allergy Society, Corpus Christi Pediatric Society, European Academy of Allergy and Clinical Immunology and Medical Dermatology Society.

Dr. Rigonan is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.